NCT03395522进行中（未招募）不适用
One-arm, Multi-center, International Prospective Study to Assess the Efficacy of Medi-tate Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 149
- 试验地点
- 13
- 主要终点
- IPSS (International Prostate Symptoms Score) Responders Rate
研究概览
简要总结
A total of up to 200 Symptomatic BPH subjects subjects will be enrolled into the study.
Study duration will be 12 months post implantation with a follow-up visits at Year 2 and Year 3.
详细描述
Primary Study Objective:
The study's primary objective is to assess the efficacy of the Medi-Tate iTind in subjects with symptomatic BPH by reduction of IPSS) (International Prostate Symptoms Score) score.
Secondary Study Objectives:
- To further evaluate the efficacy of Medi-Tate iTind as determined by increase of maximal urinary peak flow, satisfaction from the device and procedures, sex performance capabilities and ejaculation.
- Safety will be assessed by the rate of complications attributed to the Medi-Tate iTind and its implantation/retrieval procedures.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Subject signed informed consent prior to the performance of any study procedures.
- •Male with symptomatic BPH: IPSS symptom severity score ≥ 10
- •Peak urinary flow of < 12 ml/sec at flowmetry with minimum voided volume of at least 120 cc.
- •Prostate volume 25 ml to 80 ml (as assessed by TRUS)
- •Subject that is able to complete the study protocol
- •Normal Urinalysis and urine culture.
排除标准
- •Previous prostate surgery
- •Prostate cancer
- •Urethral stricture
- •Bladder stones
- •An active urinary tract infection.
- •Obstructing median lobe demonstrated by IPP grade 3 (>1 cm) as assessed by TRUS.
- •Neurological conditions potentially affecting voiding function.
- •A post void residual (PVR) volume > 250 ml measured by ultrasound
- •Previous diagnosis or treatment for Over Active Bladder
- •Acute Urinary Retention
- •Any anatomical or physiological condition that in the opinion of the investigator likely to impede successful completion of the study
- •Intra-Operation Exclusion:
- •Obstructing median lobe or any other anatomical or physiological pathology that can interfere the device implantation as assessed by cystoscopy.
结局指标
主要结局
IPSS (International Prostate Symptoms Score) Responders Rate
时间窗: at Month 6 Visit
the Proportion (%) of Total IPSS Responders (3 points) Rate
次要结局
- Total IPSS (International Prostate Symptoms Score) Score at(6 months)
- Total IPSS(International Prostate Symptoms Score) Urinary Symptoms Score(6 months)
- Total ISI (Incontinence Severity Index ) Score(6 months)
- Total Flow(6 months)
- Total residual urine(6 months)
- Total Satisfaction Rate(6 months)
- Total EJ-MSHQ ( Ejaculation- Male Sexual Health questionnaire) Score(6 months)
- Total SHIM (Sexual Health Inventory for Men ) Score(6 months)
- IPSS QoL (Quality Of Life) score(6 months)
- Recovery Success Rate(1 month)
研究者
研究点 (13)
Loading locations...
相似试验
Unknown
2 期
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).Prostatic HyperplasiaNCT00044226Milkhaus Laboratory350
招募中
不适用
Protocollo N 2014 - Benign Prostatic HyperplasiaBenign Prostatic HyperplasiaNCT06182189IRCCS San Raffaele8,000
已完成
不适用
An Observational Study of Tamsulosin in Patients With Benign Prostatic HyperplasiaBPHBenign Prostatic HyperplasiaNCT05422677Hanmi Pharmaceutical Company Limited4,698
终止
不适用
Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization ElectrodeBenign Prostatic HyperplasiaNCT02019030Olympus Corporation of the Americas5
进行中（未招募）
不适用
CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma (PMLBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)NCT05856708IRCCS San Raffaele45